milnacipran has been researched along with Mental Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridgeman, MB; Dalal, KS | 1 |
| Horii, A; Imai, T; Inohara, H; Kitahara, T; Morita, Y; Takahashi, K; Uno, A | 1 |
| Kranzler, J; Nemeroff, CB; Owens, MJ; Plott, SJ; Rao, SG; Vaishnavi, SN | 1 |
3 other study(ies) available for milnacipran and Mental Disorders
| Article | Year |
|---|---|
Neurologic and psychiatric medications.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Cyclopropanes; Dibenzazepines; Drug Therapy; Humans; Mental Disorders; Milnacipran; Nervous System Diseases; Nimodipine | 2015 |
Psychiatric comorbidities and use of milnacipran in patients with chronic dizziness.
Topics: Anxiety Disorders; Chronic Disease; Comorbidity; Cyclopropanes; Depressive Disorder; Dizziness; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2016 |
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Citalopram; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Milnacipran; Nerve Tissue Proteins; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiophenes; Venlafaxine Hydrochloride | 2004 |